(Q53174041)

12 May 2018

title

Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. (English)

1 reference

12 May 2018

0 references

4

1 reference

12 May 2018

author name string

Daisuke Kawai

1

1 reference

12 May 2018

Akinobu Takaki

2

1 reference

12 May 2018

Atsuko Nakatsuka

3

1 reference

12 May 2018

Naofumi Tamaki

5

1 reference

12 May 2018

Tetsuya Yasunaka

6

1 reference

12 May 2018

Kazuko Koike

7

1 reference

12 May 2018

Ryuichiro Tsuzaki

8

1 reference

12 May 2018

Kazuyuki Matsumoto

9

1 reference

12 May 2018

Yasuhiro Miyake

10

1 reference

12 May 2018

Hidenori Shiraha

11

1 reference

12 May 2018

Manabu Morita

12

1 reference

12 May 2018

Hirofumi Makino

13

1 reference

12 May 2018

Kazuhide Yamamoto

14

1 reference

12 May 2018

language of work or name

English

0 references

publication date

17 July 2012

1 reference

12 May 2018

published in

Hepatology

1 reference

12 May 2018

volume

56

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

912-921

1 reference

12 May 2018

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

cites work

1 reference

PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans

21 January 2018

1 reference

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

21 January 2018

1 reference

Role of mitochondria in non-alcoholic fatty liver disease

21 January 2018

1 reference

Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Why have antioxidants failed in clinical trials?

21 January 2018

1 reference

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.

21 January 2018

1 reference

Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases

21 January 2018

1 reference

Oral hydrogen water prevents chronic allograft nephropathy in rats

21 January 2018

1 reference

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

8-Hydroxy-2'-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures

21 January 2018

1 reference

The protective role of hydrogen-rich saline in experimental liver injury in mice.

21 January 2018

1 reference

Hepatic oxidoreduction-related genes are upregulated by administration of hydrogen-saturated drinking water

21 January 2018

1 reference

Effects of long-term ethanol administration in a rat total enteral nutrition model of alcoholic liver disease

21 January 2018

1 reference

Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.

21 January 2018

1 reference

Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice

21 January 2018

1 reference

PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine

21 January 2018

1 reference

Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease

21 January 2018

1 reference

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet

21 January 2018

1 reference

Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.

21 January 2018

1 reference

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

7 January 2021

Periodontal treatment decreases plasma oxidized LDL level and oxidative stress

1 reference

7 January 2021

Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice

1 reference

7 January 2021

Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?

1 reference

7 January 2021

The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25782

1 reference

12 May 2018

release_mco6f5wxafbfth7b6xeokunzri

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mco6f5wxafbfth7b6xeokunzri

24 November 2022

mapped directly with Wikidata item

PubMed ID

22505328

1 reference

12 May 2018